EndocrineICD-10: E23.2Rare; affects people of all ages, most often after pituitary surgery or head injury

Diabetes Insipidus

Also known as: DI, Arginine vasopressin deficiency, Arginine vasopressin resistance, Water diabetes

Diabetes insipidus is a rare condition in which the kidneys cannot hold on to water, so you pass very large amounts of dilute urine and feel constantly thirsty. Despite the name, it has nothing to do with blood sugar or the far more common diabetes mellitus. It happens either because the brain does not make enough of the water-conserving hormone vasopressin (central diabetes insipidus) or because the kidneys do not respond to it (nephrogenic diabetes insipidus). As long as you can drink enough to keep up, the condition is manageable, but it can quickly lead to dangerous dehydration if fluid intake is restricted, for example during illness or surgery. Treatment depends on the type and is often very effective.

Last updated November 10, 2026

Understanding Diabetes Insipidus

Diabetes insipidus is a disorder of water balance in which the kidneys cannot concentrate urine, so you pass several liters of almost colorless urine a day and drink constantly to keep up. In 2022 an international working group recommended renaming it arginine vasopressin deficiency (AVP-D) for the central form and arginine vasopressin resistance (AVP-R) for the nephrogenic form, largely because the old name is so often confused with diabetes mellitus, and the new terms are now appearing on clinic letters. It is rare: the central form affects about 1 in 25,000 people, and its commonest cause in adults is surgery or injury to the pituitary region, with transient polyuria after pituitary surgery in roughly one patient in five and a permanent problem in around 2 to 6 percent. The nephrogenic form is most often acquired from long-term lithium, which causes polyuria in 20 to 40 percent of long-term users and frank diabetes insipidus in about one in ten. Inherited forms are rarer still and usually declare themselves in infancy.

Vasopressin is made in the hypothalamus, stored in the back of the pituitary and released when the blood becomes slightly more concentrated. It acts on V2 receptors in the kidney's collecting ducts, moving aquaporin-2 water channels to the cell surface so that water is reclaimed and the urine becomes concentrated. Without that signal, or when the kidney cannot answer it, urine osmolality stays below about 300 mOsm/kg and output exceeds 50 mL per kilogram a day, about 3 liters in an adult. What protects people is thirst: as long as the thirst center works and water is within reach, sodium stays normal and the burden is the relentless drinking, urinating and broken sleep. When thirst is also damaged (adipsic DI) or access to water is lost through illness or sedation, sodium rises within hours. After pituitary surgery the course can be triphasic: polyuria in the first days, then a week or so of water retention and low sodium as stored hormone leaks from dying nerve endings, then permanent deficiency if enough cells were lost.

Diagnosis used to rest on a supervised water deprivation test, which is unpleasant and wrong about a quarter of the time. Measuring copeptin, a stable fragment released alongside vasopressin, has changed that. A baseline copeptin above 21.4 pmol/L points to the nephrogenic form, and in a 2018 New England Journal of Medicine study of 156 patients, copeptin measured after a hypertonic saline infusion separated central DI from habitual over-drinking (primary polydipsia) with 97 percent accuracy, against 77 percent for the classic test. Treatment of the central form is desmopressin, a synthetic vasopressin taken as a tablet, melt or nasal spray, which abolishes the polyuria in most people. Its main hazard is the opposite problem: if you keep drinking from habit while the drug stops water loss, sodium falls, and low sodium is the commonest reason people on desmopressin end up in hospital. Nephrogenic DI responds partly to a low-salt diet, thiazide diuretics and, in lithium cases, amiloride, which blocks lithium's entry into collecting-duct cells.

There is no herb, supplement or diet that restores vasopressin or makes the kidney respond to it, and this page lists none, because listing something would imply otherwise. Water is the only essential natural treatment, taken to thirst, and the one thing never to be restricted on anyone's advice. A few things from the natural-health world are worth knowing about precisely because they can do harm. Products promoted to reduce urination or 'support the pituitary' have no trials in this condition. Herbal diuretics such as dandelion, juniper and horsetail add to water loss and should be avoided. Licorice root raises blood pressure and lowers potassium, and low potassium itself impairs the kidney's ability to concentrate urine. Two blood findings are worth asking about rather than supplementing blindly: a high calcium or a low potassium level can cause a reversible nephrogenic picture, so a metabolic panel with calcium and potassium is part of the work-up, and correcting those under medical supervision can resolve it. Caffeine and alcohol both increase urine output modestly, which matters more when your reserve is already thin.

The most common mistake is treating desmopressin as a drug that fixes everything and keeping the old drinking habit. Desmopressin removes the body's safety valve: with it on board you cannot excrete a water load, so drinking by routine rather than by thirst dilutes sodium, and headache, nausea, confusion and in the worst cases seizures follow. Most endocrinologists advise letting the drug wear off once a day, or at least a few times a week, so that you notice the urine flow return before the next dose; that period of breakthrough polyuria is a sign the dose is right, not that it has failed. The second mistake happens in hospitals: being kept nil by mouth, sedated or admitted to a ward that does not know the condition, and having desmopressin omitted or fluids withheld. In England a 2016 national patient safety alert followed four deaths and dozens of incidents in seven years from exactly this. Carry a medical alert card, bring your own desmopressin to any admission, and make sure the diagnosis is written at the top of your chart.

At a Glance

Common symptoms
Passing very large volumes of pale, dilute urine, often many liters per day, Intense, persistent thirst, especially a craving for cold water, Waking repeatedly at night to urinate or, in children, bedwetting
Main treatments
Desmopressin, a synthetic form of vasopressin given as a tablet, nasal spray, or injection, for the central type, Treating the underlying cause, such as a pituitary tumor or electrolyte imbalance, For the nephrogenic type: a low-salt, lower-protein diet and thiazide diuretics, which paradoxically reduce urine output
Category
Endocrine · Rare; affects people of all ages, most often after pituitary surgery or head injury
See a doctor if
You are urinating far more than usual and cannot quench your thirst

Symptoms

Passing very large volumes of pale, dilute urine, often many liters per day
Intense, persistent thirst, especially a craving for cold water
Waking repeatedly at night to urinate or, in children, bedwetting
Dry mouth and dry skin
Fatigue and difficulty concentrating from disrupted sleep
Signs of dehydration such as dizziness, headache, or confusion if fluids are limited
Poor growth, irritability, and fever in infants

Causes

  • Damage to the hypothalamus or pituitary from surgery, tumors, head injury, or inflammation (central type)
  • Inherited gene mutations affecting vasopressin production or kidney response
  • Long-term lithium use and certain other medications (nephrogenic type)
  • High calcium or low potassium levels that impair kidney concentrating ability
  • Chronic kidney disease or urinary tract obstruction
  • Pregnancy, when an enzyme from the placenta breaks down vasopressin (usually temporary)

Risk Factors

  • Recent brain or pituitary surgery, or radiation to the head
  • Traumatic brain injury
  • A family history of diabetes insipidus
  • Long-term treatment with lithium
  • Conditions that raise blood calcium, such as overactive parathyroid glands

Diagnosis

  • Measurement of 24-hour urine volume and urine concentration (osmolality)
  • Blood tests for sodium, glucose, calcium, and potassium to rule out other causes of excess urination
  • A supervised water deprivation test, often with a dose of synthetic vasopressin to distinguish central from nephrogenic types
  • Copeptin blood testing, a newer marker that reflects vasopressin levels
  • MRI of the brain and pituitary when a central cause is suspected

Treatment

  • Desmopressin, a synthetic form of vasopressin given as a tablet, nasal spray, or injection, for the central type
  • Treating the underlying cause, such as a pituitary tumor or electrolyte imbalance
  • For the nephrogenic type: a low-salt, lower-protein diet and thiazide diuretics, which paradoxically reduce urine output
  • Reviewing medications with your doctor if lithium or another drug is responsible (never stop a prescribed medicine on your own)
  • Nonsteroidal anti-inflammatory drugs in some nephrogenic cases, under medical supervision
  • Supportive: always keeping water available and drinking to thirst, since thirst is your main protection against dehydration
  • Supportive: wearing a medical alert bracelet so emergency staff know you need fluids

What matters day to day

  • Drink to thirst and keep water within reach everywhere, including beside the bed, in the car and at work: thirst is your protection against high sodium, and the dangerous episodes happen when access to water is lost, not when intake is high.
  • If you take desmopressin, let it wear off and allow urine output to return once a day, or at least several times a week, before the next dose, and drink only when thirsty while the drug is working: this is the simplest guard against low sodium, which is the main cause of hospital admission in treated central DI.
  • Agree a sick-day plan with your clinician before you need it: vomiting, diarrhea or fever changes both your water losses and your ability to absorb tablets, and a day of not keeping fluids down is a reason to be seen the same day, not to wait it out.
  • Wear a medical alert bracelet and carry a written card naming the condition, your desmopressin dose and the warning that fluids must never be withheld: emergency and surgical staff rarely see this condition, and omitted doses on hospital wards have caused deaths.
  • If you take lithium, have sodium, creatinine and urine volume reviewed at least every 6 months and report new thirst or night-time urination early: lithium-induced DI is often reversible in its first months and becomes permanent if ignored for years, and amiloride can protect the kidney while lithium continues.
  • Keep caffeine and alcohol modest and avoid saunas or long hot workouts without water to hand: both drinks increase urine output, and heat adds sweat losses on top of a kidney that already cannot save water.

Prevention

  • Most cases cannot be prevented, but complications can be
  • Carry water and never let fluid intake be restricted without medical supervision
  • Have kidney function and electrolytes checked regularly if you take lithium
  • Tell any surgeon or hospital team about your diagnosis before procedures
  • Take desmopressin exactly as prescribed to avoid both dehydration and water overload

When to See a Doctor

  • You are urinating far more than usual and cannot quench your thirst
  • A child suddenly starts wetting the bed or drinking excessively
  • You develop confusion, severe headache, rapid heartbeat, or fainting, especially if you have been unable to drink (emergency)
  • You have diabetes insipidus and become ill with vomiting or diarrhea
  • You feel bloated, nauseous, or confused after taking desmopressin, which can signal low sodium

Frequently Asked Questions

References

  1. Fenske W, Refardt J, Chifu I, et al.. A copeptin-based approach in the diagnosis of diabetes insipidus. New England Journal of Medicine (2018)
  2. Arima H, Cheetham T, Christ-Crain M, et al.. Changing the name of diabetes insipidus: a position statement of the Working Group for Renaming Diabetes Insipidus. Journal of Clinical Endocrinology and Metabolism (2022)
  3. Atila C, Loughrey PB, Garrahy A, et al.. Central diabetes insipidus from a patient's perspective: management, psychological co-morbidities, and renaming of the condition: results from an international web-based survey. Lancet Diabetes and Endocrinology (2022)
  4. Christ-Crain M, Bichet DG, Fenske WK, et al.. Diabetes insipidus. Nature Reviews Disease Primers (2019)
  5. Baldeweg SE, Ball S, Brooke A, et al.. Society for Endocrinology clinical guidance: inpatient management of cranial diabetes insipidus. Endocrine Connections (2018)
  6. NHS England. Patient safety alert: risk of severe harm or death when desmopressin is omitted or delayed in patients with cranial diabetes insipidus (2016)
  7. Garofeanu CG, Weir M, Rosas-Arellano MP, et al.. Causes of reversible nephrogenic diabetes insipidus: a systematic review. American Journal of Kidney Diseases (2005)
  8. Bedford JJ, Weggery S, Ellis G, et al.. Lithium-induced nephrogenic diabetes insipidus: renal effects of amiloride. Clinical Journal of the American Society of Nephrology (2008)
  9. National Institute of Diabetes and Digestive and Kidney Diseases. Diabetes Insipidus (2024)View source
  10. MedlinePlus, National Library of Medicine. Diabetes Insipidus (2024)View source

Related Conditions

Have questions about Diabetes Insipidus?

Ask Mother Nature AI for personalized, evidence-based guidance.

Medical Disclaimer: This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider.

Content reviewed against peer-reviewed medical literature and clinical guidelines. Read our editorial standards.